Reunion Neuroscience (REUN)
Reunion Neuroscience is an early stage pharmaceutical company developing new molecules to treat mental health conditions. The company’s team is composed of successful entrepreneurs and scientific leaders with deep experience in nearly every aspect of pharmaceutical development.
Previously a part of Field Trip Health Ltd. under the name Field Trip Discovery, Reunion is now an independent public company focused on developing therapeutics. The board unanimously approved the reorganization in April of 2022, with Field Trip Health now being renamed Reunion Neuroscience Inc.